Three-dimensional magnetic cell array for evaluation of anti-proliferative effects of chemo-thermo treatment on cancer spheroids

Biotechnology and Bioprocess Engineering

Volumn 20, Issue 3, 2015, Pages 488-497

  Yamamoto, Shuhei ^a   Okochi, Mina ^b   Jimbow, Kowichi ^c   Honda, Hiroyuki ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3D cell culture; cell patterning; hyperthermia; melanoma; NPrCAP; Spheroid

Indexed keywords

CELL CULTURE; CELLS; COLLAGEN; DERMATOLOGY; DISEASES; HEAT TREATMENT; MAGNETISM; ONCOLOGY;

3-D CELL CULTURE; CELL-PATTERNING; HYPERTHERMIA; MELANOMA; NPRCAP; SPHEROID;

CYTOLOGY;

4 S CYSTEAMINYLPHENOL; COLLAGEN GEL; N PROPIONYL 4 CYSTEAMINYLPHENOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL COUNT; CELL LABELING; CHEMOSENSITIVITY; CONTROLLED STUDY; EVALUATION STUDY; HEAT TREATMENT; HYPERTHERMIC THERAPY; MAGNETISM; MELANOGENESIS; MELANOMA CELL; MINIMUM INHIBITORY CONCENTRATION; MONOLAYER CULTURE; MOUSE; NONHUMAN; TUMOR SPHEROID;

EID: 84937890023     PISSN: 12268372     EISSN: 19763816     Source Type: Journal    
DOI: 10.1007/s12257-014-0724-y     Document Type: Article

References (44)

1. Birgersdotter, A., R. Sandberg, and I. Ernberg (2005) Gene expression perturbation in vitro-A growing case for threedimensional (3D) culture systems. Seminars in Cancer Biol. 15: 405–412.
2. Petersen, O. W., L. Ronnovjessen, A. R. Howlett, and M. J. Bissell (1992) Interaction with basement-membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial-cells. Proc. Nat. Acad. Sci. U.S.A. 89: 9064–9068.
3. Ivascu, A. and M. Kubbies (2006) Rapid generation of singletumor spheroids for high-throughput cell function and toxicity analysis. J. Biomol. Screening 11: 922–932.
4. Kang, H. G., J. M. Jenabi, J. S. Zhang, N. Keshelava, H. Shimada, W. A. May, T. Ng, C. P. Reynolds, T. J. Triche, and P. H. B. Sorensen (2007) E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 67: 3094–3105.
5. Kunz-Schughart, L. A., J. P. Freyer, F. Hofstaedter, and R. Ebner (2004) The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J. Biomol. Screening. 9: 273–285.
6. Kim, J. B. (2005) Three-dimensional tissue culture models in cancer biology. Seminars in Cancer Biol. 15: 365–377.
7. Kenny, P. A., G. Y. Lee, C. A. Myers, R. M. Neve, J. R. Semeiks, P. T. Spellman, K. Lorenz, E. H. Lee, M. H. Barcellos-Hoff, O. W. Petersen, J. W. Gray, and M. J. Bissell (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 1: 84–96.
8. Fennema, E., N. Rivron, J. Rouwkema, C. van Blitterswijk, and J. de Boer (2013) Spheroid culture as a tool for creating 3D complex tissues. Trends in Biotechnol. 31: 108–115.
9. Aref, A. R., R. Y. J. Huang, W. M. Yu, K. N. Chua, W. Sun, T. Y. Tu, J. Bai, W. J. Sim, I. K. Zervantonakis, J. P. Thiery, and R. D. Kamm (2013) Screening therapeutic EMT blocking agents in a three-dimensional microenvironment. Integrative Biol. 5: 381–389.
10. Yamamoto, S., M. M. Hotta, M. Okochi, and H. Honda (2014) Effect of vascular formed endothelial cell network on the invasive capacity of melanoma using the in vitro 3D co-culture patterning model. PloS one. 9: e103502.
11. Okochi, M., T. Matsumura, S. Yamamoto, E. Nakayama, K. Jimbow, and H. Honda (2013) Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three-dimensional magnetic cell culture array. Biotechnol. Prog. 29: 135–142.
12. Ino, K., M. Okochi, and H. Honda (2009) Application of magnetic force-based cell patterning for controlling cell-cell interactions in angiogenesis. Biotechnol. Bioeng. 102: 882–890.
13. Okochi, M., T. Matsumura, and H. Honda (2013) Magnetic force-based cell patterning for evaluation of the effect of stromal fibroblasts on invasive capacity in 3D cultures. Biosens.s Bioelectron. 42: 300–307.
14. Ino, K., M. Okochi, N. Konishi, M. Nakatochi, R. Imai, M. Shikida, A. Ito, and H. Honda (2008) Cell culture arrays using magnetic force-based cell patterning for dynamic single cell analysis. Lab Chip. 8: 134–142.
15. Okochi, M., S. Takano, Y. Isaji, T. Senga, M. Hamaguchi, and H. Honda (2009) Three-dimensional cell culture array using magnetic force-based cell patterning for analysis of invasive capacity of BALB/3T3/v-src. Lab Chip. 9: 3378–3384.
16. Shimizu, K., A. Ito, T. Yoshida, Y. Yamada, M. Ueda, and H. Honda (2007) Bone tissue engineering with human mesenchymal stem cell sheets constructed using magnetite nanoparticles and magnetic force. J. Biomed. Mat. Res. Part B-Appl. Biomat. 82B: 471–480.
17. Balch, C. M., A. C. Buzaid, S. J. Soong, M. B. Atkins, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton, J. M. Kirkwood, K. M. McMasters, M. F. Mihm, D. L. Morton, D. S. Reintgen, M. I. Ross, A. Sober, J. A. Thompson, and J. F. Thompson (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 19: 3635–3648.
18. Ito, S. and K. Wakamatsu (2008) Chemistry of mixed melanogenesis-Pivotal roles of dopaquinone. Photochem. Photobiol. 84: 582–592.
19. Ito, Y. and K. Jimbow (1987) Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse-rational basis for its application to melanoma chemotherapy. Cancer Res. 47: 3278–3284.
20. Thomas, P. D., H. Kishi, H. M. Cao, M. Ota, T. Yamashita, S. Singh, and K. Jimbow (1999) Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs. J. Investigative Dermatol. 113: 928–934.
21. Ito, S., A. Nishigaki, Y. Ishii-Osai, M. Ojika, K. Wakamatsu, T. Yamashita, Y. Tamura, A. Ito, H. Honda, E. Nakayama, and K. Jimbow (2012) Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models. Biochem. Pharmacol. 84: 646–653.
22. Alena, F., T. Iwashina, A. Gili, and K. Jimbow (1994) Selective in-vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in-vitro and in-vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res. 54: 2661–2666.
23. Pankovich, J. M. and K. Jimbow (1991) Tyrosine transport in a human-melanoma cell-line as a basis for Selective transport of cytotoxic analogs. Biochem. J. 280: 721–725.
24. Tandon, M., P. D. Thomas, M. Shokravi, S. Singh, S. Samra, D. Chang, and K. Jimbow (1998) Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-Scysteaminylphenol. Biochem. Pharmacol. 55: 2023–2029.
25. Miura, S., T. Ueda, K. Jimbow, S. Ito, and K. Fujita (1987) Synthesis of cysteinylphenol, cysteaminylphenol, and related-compounds, and in vivo evaluation of antimelanoma effect. Arch. Dermatol. Res. 279: 219–225.
26. Ito, A., M. Fujioka, T. Yoshida, K. Wakamatsu, S. Ito, T. Yamashita, K. Jimbow, and H. Honda (2007) 4-S-Cysteaminylphenolloaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci. 98: 424–430.
27. Shinkai, M., M. Yanase, H. Honda, T. Wakabayashi, J. Yoshida, and T. Kobayashi (1996) Intracellular hyperthermia for cancer using magnetite cationic liposomes: In vitro study. Japanese J. Cancer Res. 87: 1179–1183.
28. Kawai, N., A. Ito, Y. Nakahara, H. Honda, T. Kobayashi, M. Futakuchi, T. Shirai, K. Tozawa, and K. Kohri (2006) Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate 66: 718–727.
29. Jimbow, K., Y. Tamura, A. Yoneta, T. Kamiya, I. Ono, T. Yamashita, A. Ito, H. Honda, K. Wakamatsu, S. Ito, S. Nohara, E. Nakayama, and T. Kobayashi (2012) Conjugation of magnetite nanoparticles with melanogenesis substrate, NPrCAP provides melanoma targeted, in situ peptide vaccine immunotherapy through HSP production by chemo-thermotherapy. J. Biomat. Nanobiotechnol. 3: 140–153.
30. Ito, A., M. Yamaguchi, N. Okamoto, Y. Sanematsu, Y. Kawabe, K. Wakamatsu, S. Ito, H. Honda, T. Kobayashi, E. Nakayama, Y. Tamura, M. Okura, T. Yamashita, K. Jimbow, and M. Kamihira (2013) T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles. Nanomed. 8: 891–902.
31. Jimbow, K., Y. Ishii-Osai, S. Ito, Y. Tamura, A. Ito, A. Yoneta, T. Kamiya, T. Yamashita, H. Honda, K. Wakamatsu, K. Murase, S. Nohara, E. Nakayama, T. Hasegawa, I. Yamamoto, and T. Kobayashi (2013) Melanoma-targeted chemothermotherapy and in situ peptide immunotherapy through HSP production by using melanogenesis substrate, NPrCAP, and magnetite nanoparticles. J. Skin Cancer 2013: 742925.
32. Depauwgillet, M., Y. M. Christiane, J. M. Foidart, and R. J. B. Bassleer (1988) Analysis of tridimensional mixed cultures of mouse B-16 melanoma-cells and 3T3 fibroblasts. Anticancer Res. 8: 153–160.
33. Tomihari, M., J. S. Chung, H. Akiyoshi, P. D. Cruz, and K. Ariizumi (2010) DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by Inhibiting the activation of tumor-reactive T cells. Cancer Res. 70: 5778–5787.
34. Valeriote, F. and H. Lin (1975) Synergistic interaction of anticancer agents-cellular perspective. Cancer Chem. Rep. Part 1. 59: 895–900.
35. Friedl, P. and S. Alexander (2011) Cancer invasion and the microenvironment: Plasticity and reciprocity. Cell. 147: 992–1009.
36. Wartenberg, M., S. Gronczynska, M. M. Bekhite, T. Saric, W. Niedermeier, J. Hescheler, and H. Sauer (2005) Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int. J. Cancer. 113: 229–240.
37. Furukawa, T., T. Kubota, M. Watanabe, T. Takahara, H. Yamaguchi, T. Takeuchi, S. Kase, S. Kodaira, K. Ishibiki, M. Kitajima, and R. M. Hoffman (1992) High in vitro-in vivo correlation of drug response using sponge-gel-supported 3-dimensional histoculture and the MTT end-point. Int. J. Can. 51: 489–498.
38. Ho, W. J., E. A. Pham, J. W. Kim, C. W. Ng, J. H. Kim, D. T. Kamei, and B. M. Wu (2010) Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci. 101: 2637–2643.
39. Ohmori, T., J. L.Yang, J. O.Price, and C. L. Arteaga (1998) Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Exp. Cell Res. 245: 350–359.
40. Yeo, E. J., Y. S. Chun, and J. W. Park (2004) New anticancer strategies targeting HIF-1. Biochem. Pharmacol. 68: 1061–1069.
41. Viale, M., C. Cordazzo, B. Cosimelli, D. de Totero, P. Castagnola, C. Aiello, E. Severi, G. Petrillo, M. Cianfriglia, and D. Spinelli (2009) Inhibition of MDR1 activity in vitro by a novel class of diltiazem analogues: Toward new candidates. J. Med. Chem. 52: 259–266.
42. Longati, P., X. H. Jia, J. Eimer, A. Wagman, M. R. Witt, S. Rehnmark, C. Verbeke, R. Toftgard, M. Lohr, and R. L. Heuchel (2013) 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 13: 95.
43. Oshikata, A., T. Matsushita, and R. Ueoka (2011) Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. J. Biosci. Bioeng. 111: 590–593.
44. Yoshii, Y, A. Waki, K. Yoshida, A. Kakezuka, M. Kobayashi, H. Namiki, Y. Kuroda, Y. Kiyono, H. Yoshii, T. Furukawa, T. Asai, H. Okazawa, J. G. Gelovani, and Y. Fujibayashi (2011) The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation. Biomat. 32: 6052–6058.